The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in sales , its intellectual property lapse created a https://sites2000.com/story11225977/sildenafil-and-big-pharma-a-uncertain-opportunity